WENDY PRICE: Open Payments
NPI 1174078646 · CLOVIS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,168 in 52 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,168
Food & beverage: $1,082Education: $86
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 14 | $197 |
| Caris MPI, Inc. | 6 | $169 |
| AstraZeneca Pharmaceuticals LP | 6 | $156 |
| PUMA BIOTECHNOLOGY, INC. | 8 | $150 |
| Gilead Sciences, Inc. | 3 | $139 |
| Novartis Pharmaceuticals Corporation | 4 | $98 |
| TerSera Therapeutics LLC | 3 | $87 |
| Merck Sharp & Dohme LLC | 2 | $53 |
| Genentech USA, Inc. | 2 | $44 |
| Menarini Silicon Biosystems, Inc. | 2 | $39 |
Products named: Enhertu, MI CANCER SEEK, NERLYNX, KISQALI, Zoladex, Trodelvy, Phesgo, Cellsearch.
Industry payments across CA — which companies pay providers there.
